![](/img/cover-not-exists.png)
Adalimumab Safety in Crohnʼs Disease Patients: Open-Label Maintenance Following the Gain and CHARM Trials
Colombel, J. F., Rutgeerts, P., Sandborn, W. J., Panaccione, R., Lau, W., Lomax, K. G., Pollack, P. F.Volume:
102
Journal:
American Journal of Gastroenterology
DOI:
10.14309/00000434-200709002-01031
Date:
September, 2007
File:
PDF, 83 KB
2007